What is Semaglutide?
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for treating type 2 diabetes and obesity. It helps lower blood sugar levels and reduce appetite by acting like the hormone GLP-1.
Key features of Semaglutide:
- Long-acting - only needs to be taken once weekly
- More effective than other GLP-1 drugs for weight loss
- Convenient administration through a pre-filled, disposable pen device
Semaglutide was approved by the FDA in 2017 under the brand names Ozempic® for diabetes and Wegovy™ for chronic weight management. Generic versions are now available as well.